XOOMAR

Nautilus Biotechnology (NAUT)

Nautilus Biotechnology on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

5.8M

Short interest

settlement 2026-09-30

1.4

Days to cover

-1.8 days vs prior

47.8%

Short share of volume

2026-10-23

33,326

Fails to deliver

settlement 2026-09-25

Tue 27 Oct

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-10-23.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 30 September 2026, short interest in NAUT is 5,771,054 shares, up 1,957,025 shares over the last month. Over the last 48 readings it ranged from 175,233 shares (15 September 2025) to 5,771,054 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 4.1M shares a day that is 1.4 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/naut" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-09-305,771,054+41.4%4,066,7061.42
2026-09-154,082,014+7.0%1,259,6823.24
2026-08-313,814,029+20.9%591,9046.44
2026-08-143,154,786+38.8%859,5623.67
2026-07-312,273,103+56.9%835,9182.72
2026-07-151,448,757+74.7%1,113,1001.30
2026-06-30829,522+53.3%1,329,6491.00
2026-06-15541,139-28.8%407,8371.33
2026-05-29760,157-7.9%432,6651.76
2026-05-15825,026+15.3%390,8652.11
2026-04-30715,637+12.0%289,6622.47
2026-04-15638,943-5.3%318,2682.01
2026-03-31674,952+51.1%503,0391.34
2026-03-13446,652+13.9%189,2002.36
2026-02-27392,211+14.0%271,4361.44
2026-02-13344,071+12.0%156,6332.20
2026-01-30307,305-16.6%196,8851.56
2026-01-15368,545-17.2%234,6161.57
2025-12-31445,221+14.3%181,9902.45
2025-12-15389,399-7.5%282,0301.38
2025-11-28420,880+7.8%426,6491.00
2025-11-14390,590+112.1%655,2731.00
2025-10-31184,156+2.1%867,3481.00
2025-10-15180,291-4.2%286,0151.00
2025-09-30188,196+7.4%475,6511.00
2025-09-15175,233-22.2%348,3571.00
2025-08-29225,333+0.3%175,9431.28
2025-08-15224,727-16.2%213,9551.05
2025-07-31268,176+11.2%177,7941.51
2025-07-15241,258-18.9%163,2971.48
2025-06-30297,582-75.9%953,9641.00
2025-06-131,234,418+17.6%193,2766.39
2025-05-301,049,719+11.4%135,4767.75
2025-05-15942,225+8.6%202,4824.65
2025-04-30867,410+58.0%200,1624.33
2025-04-15548,875+29.3%179,6453.06
2025-03-31424,523+20.5%191,3852.22
2025-03-14352,327+20.8%103,4923.40
2025-02-28291,638+3.0%141,7622.06
2025-02-14283,234+4.1%87,6843.23
2025-01-31272,034-68.8%108,0312.52
2025-01-15872,903-15.6%145,9655.98
2024-12-311,033,962-14.1%189,0835.47
2024-12-131,204,275+2.5%150,2628.01
2024-11-291,174,419+0.4%114,57210.25
2024-11-151,169,903-3.5%151,7327.71
2024-10-311,212,317+0.5%78,44415.45
2024-10-151,206,747-0.3%44,36127.20

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 23 October 2026, the short share of NAUT volume is 47.8%, down 10.5 points over the last five sessions. Over the last 30 readings it ranged from 36.1% (15 September 2026) to 62.1% (17 September 2026). The latest reading is 4.8 points below the 30-session average of 52.6%, on 8.6M shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-10-234.1M8.6M47.8%58,592
2026-10-222.3M4.1M54.6%9,363
2026-10-212.9M4.8M60.1%22,250
2026-10-203.4M6.5M53.0%137,443
2026-10-194.8M9.1M52.8%33,053
2026-10-162.0M3.4M58.3%469,675
2026-10-152.2M4.9M44.3%447,019
2026-10-142.6M5.0M53.1%32,653
2026-10-132.7M5.0M54.9%480,663
2026-10-125.0M8.1M61.9%792,509
2026-10-097.3M13.5M53.9%973,184
2026-10-081.9M3.6M53.8%37,087
2026-10-073.7M7.4M49.4%42,369
2026-10-063.8M7.2M53.4%67,305
2026-10-058.7M15.2M57.0%360,684
2026-10-023.9M6.8M57.4%41,599
2026-10-012.5M5.3M46.7%15,318
2026-09-303.0M5.8M51.3%36,640
2026-09-297.1M12.3M58.1%160,324
2026-09-281.4M2.8M49.7%5,305
2026-09-25186K412K45.3%1,000
2026-09-24166K286K58.1%0
2026-09-23122K198K61.7%0
2026-09-22109K293K37.3%1,200
2026-09-21177K441K40.2%0
2026-09-18168K278K60.3%0
2026-09-17240K386K62.1%0
2026-09-16428K771K55.4%96
2026-09-15163K452K36.1%40,878
2026-09-14352K715K49.3%13,792

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 25 September 2026, the fails-to-deliver balance in NAUT is 33,326 shares, up 22,488 shares over the last settlement date. Over the last 30 readings it ranged from 6 shares (6 October 2025) to 33,326 shares (25 September 2026). The latest reading sits at the top of that range.

SettlementShares failedPriceValue
2026-09-2533,326$0.99$33K
2026-09-2410,838$0.95$10K
2026-09-165,962$0.89$5K
2026-09-152,566$0.91$2K
2026-09-1015,188$1.12$17K
2026-08-133,130$0.90$3K
2026-06-264,644$2.27$11K
2026-06-15124$2.24$278
2026-05-04519$2.70$1K
2026-04-10524$3.04$2K
2026-04-093,090$3.13$10K
2026-04-02172$3.36$578
2026-03-3011,469$3.48$40K
2026-03-2513$3.95$51
2026-03-16159$2.33$370
2026-03-12105$2.42$254
2026-02-1013,423$2.16$29K
2025-12-193,844$1.94$7K
2025-11-251,694$2.07$4K
2025-10-303,466$1.41$5K
2025-10-066$0.88$5
2025-09-118,646$0.71$6K
2025-09-095,728$0.70$4K
2025-07-0859$0.80$47
2025-06-1286$0.73$63
2025-06-10624$0.77$480
2025-06-06683$0.74$505
2025-06-05548$0.77$422
2025-05-1672$0.87$63
2025-05-1583$0.88$73

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for NAUT in the last 90 days. The most recent filings are listed below. Latest filing: AH Bio Fund II, L.P. (TenPercentOwner) on 2026-06-02.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-06-02AH Bio Fund II, L.P.TenPercentOwnerSell384K$2.35$902K972K
2026-06-02AH Bio Fund II, L.P.TenPercentOwnerSell4.6M$2.35$10.8M11.7M
2026-06-02AH Equity Partners Bio II, L.L.C.10% ownerSell384K$2.35$902K972K
2026-06-02AH Equity Partners Bio II, L.L.C.10% ownerSell4.6M$2.35$10.8M11.7M
2026-03-04Patel Sujal MCEO, President, and SecretaryBuy25K$2.61$65K10.4M
2025-11-06Suzuki KentaroChief Marketing OfficerBuy4K$1.49$6K4K
2025-09-08Patel Sujal MCEO, President, and SecretaryBuy84K$0.68$57K10.3M
2025-09-05Patel Sujal MCEO, President, and SecretaryBuy117K$0.67$79K10.3M
2025-09-04Murphy Matthew B.General CounselBuy20K$0.64$13K74K
2025-05-29Mowry AnnaCFO and TreasurerBuy15K$0.77$12K83K
2025-05-12Mallick ParagChief ScientistBuy2K$0.73$1K20.5M
2025-05-08Mallick ParagChief ScientistBuy12K$0.73$9K20.5M
2025-03-20Patel Sujal MCEO, President, and SecretaryBuy24K$1.00$24K10.1M
2025-03-19Patel Sujal MCEO, President, and SecretaryBuy53K$0.99$53K10.1M
2024-09-23Godwin Mary E.Senior VP, OperationsSell47K$2.87$135K0
2024-09-23Godwin Mary E.Senior VP, OperationsExercise or conversion47K$0.46$22K47K
2024-09-17Godwin Mary E.Senior VP, OperationsExercise or conversion35K$0.46$16K35K
2024-09-17Godwin Mary E.Senior VP, OperationsSell35K$2.85$100K0
2024-03-11Patel Sujal MCEO, President, and SecretaryBuy12K$2.84$34K10.1M
2024-03-08Patel Sujal MCEO, President, and SecretaryBuy2K$2.99$7K10.1M
2024-03-07Patel Sujal MCEO, President, and SecretaryBuy19K$2.89$54K10.1M
2024-03-06Patel Sujal MCEO, President, and SecretaryBuy9K$2.70$25K10.0M
2024-03-05Patel Sujal MCEO, President, and SecretaryBuy7K$2.65$20K10.0M
2022-09-27Sankar SubramanianSenior VP, Product DevelopmentBuy5K$2.03$10K91K
2022-09-26Sankar SubramanianSenior VP, Product DevelopmentBuy10K$2.03$20K86K
2022-09-23Weld Gwen EChief People OfficerBuy30K$2.03$61K30K
2022-09-16Sankar SubramanianSenior VP, Product DevelopmentBuy35K$2.16$76K75K
2022-09-15Sankar SubramanianSenior VP, Product DevelopmentBuy40K$2.19$88K40K
2022-08-19Mowry AnnaCFO and TreasurerBuy18K$2.30$40K57K
2022-08-15Murphy Matthew B.General CounselBuy8K$2.84$21K54K
2022-08-12Murphy Matthew B.General CounselBuy3K$2.85$7K47K
2022-08-08Patel Sujal MCEO, President, and SecretaryBuy8K$2.93$24K10.0M
2022-08-05Patel Sujal MCEO, President, and SecretaryBuy42K$2.92$122K10.0M
2022-06-27Mowry AnnaCFO and TreasurerBuy6K$2.75$15K39K
2022-05-12Murphy Matthew B.General CounselGrant10K$3.28$33K44K
2022-05-09Patel Sujal MCEO, President, and SecretaryBuy50K$3.96$198K10.0M
2022-03-04Patel Sujal MCEO, President, and SecretaryExercise or conversion100$10.00$1K9.9M
2022-03-03Patel Sujal MCEO, President, and SecretaryBuy50K$3.60$180K9.9M
2021-12-21Mallick ParagChief ScientistGift210K$0.00$020.5M
2021-12-08PERCEPTIVE LIFE SCIENCES MASTER FUND LTDTenPercentOwnerBuy200K$5.36$1.1M9.1M
2021-12-01Posard Matthew L.DirectorBuy10K$4.45$44K50K
2021-12-01Posard Matthew L.DirectorBuy10K$4.46$45K40K
2021-12-01Posard Matthew L.DirectorBuy10K$4.50$45K30K
2021-12-01Patel Sujal MCEO, President, and SecretaryBuy88K$4.73$416K9.9M
2021-11-30Posard Matthew L.DirectorBuy20K$4.57$91K20K
2021-11-30Patel Sujal MCEO, President, and SecretaryBuy162K$4.72$765K9.8M
2021-11-24Mowry AnnaCFO and TreasurerBuy15K$4.58$69K33K
2021-11-15McIlwain Matthew SDirectorBuy100K$5.30$530K459K
2021-08-26McIlwain Matthew SDirectorBuy12K$7.71$90K359K
2021-08-25McIlwain Matthew SDirectorBuy12K$7.74$91K347K
2021-08-24McIlwain Matthew SDirectorBuy14K$7.68$104K336K
2021-08-13Murphy Matthew B.General CounselBuy5K$7.56$38K34K
2021-08-12Mowry AnnaCFO and TreasurerBuy18K$7.71$135K18K
2021-06-09ALTMAN MICHAEL SETHDirectorConversion499Kprice not stated in the filingnot stated499K
2021-06-09ALTMAN MICHAEL SETHDirectorConversion3.6Mprice not stated in the filingnot stated3.6M
2021-06-09ALTMAN MICHAEL SETHDirectorConversion499Kprice not stated in the filingnot stated0
2021-06-09PERCEPTIVE LIFE SCIENCES MASTER FUND LTDOtherBuy5.5M$10.00$55.0M6.0M
2021-06-09PERCEPTIVE LIFE SCIENCES MASTER FUND LTDOtherOther transaction2.9Mprice not stated in the filingnot stated8.9M
2021-05-24PERCEPTIVE LIFE SCIENCES MASTER FUND LTDOtherBuy7K$10.05$71K497K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

5 holders report 5% or more of NAUT in their latest filing, all on Schedule 13D (active intent). The largest reported stake is Parag Mallick at 17.6% of the class (22,557,411 shares), filed 2026-03-04 for an event on 2026-03-02.

FiledFormHolderSharesOf classEvent
2026-09-1113D/Ano. 4Marc L. Andreessenindividual6.3M4.9%2026-09-09
2026-09-1113D/Ano. 4Benjamin A. Horowitzindividual6.3M4.9%2026-09-09
2026-09-1113D/Ano. 4AH Bio Fund II, L.P.partnership5.8M4.5%2026-09-09
2026-09-1113D/Ano. 4AH Equity Partners Bio II, L.L.C.other entity5.8M4.5%2026-09-09
2026-09-1113D/Ano. 4Andreessen Horowitz LSV Fund II, L.P.partnership481K0.4%2026-09-09
2026-09-1113D/Ano. 4AH Equity Partners LSV II, L.L.C.other entity481K0.4%2026-09-09
2026-08-1413D/Ano. 5Perceptive Advisors LLCinvestment adviser11.6M9.1%2026-06-30
2026-08-1413D/Ano. 5Joseph Edelmanindividual11.6M9.1%2026-06-30
2026-08-1413D/Ano. 5Perceptive Life Sciences Master Fund, Ltd.corporation11.5M9.1%2026-06-30
2026-08-1413D/Ano. 5C2 Life Sciences LLCcorporation166K0.1%2026-06-30
2026-03-0413D/Ano. 2Parag Mallickindividual22.6M17.6%2026-03-02
2026-03-0413D/Ano. 3Sujal Patelindividual21.2M16.3%2026-03-02

13F holders

Tracked managers holding NAUT at their latest 13F. JSON

4 of the 30 tracked managers held NAUT at their latest 13F, $5.3M in total at quarter-end prices. Citadel Advisors is the largest at $3.5M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.

FundQuarterSharesValueOf portfolioChange in shares
Citadel Advisors2026-06-301.9M$3.5M0.00%new
Renaissance Technologies2026-06-30691K$1.3M0.00%+425K
Millennium Management2026-06-30189K$353K0.00%-1.1M
Point72 Asset Management2026-06-3068K$127K0.00%-15K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Nautilus Biotechnology in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Nautilus Biotechnology (NAUT), SEC CIK 1808805, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-25.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-09-11.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-28.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-02.JSON and CSV
Company record
EDGAR filing index for CIK 1808805Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of NAUT is sold short?
5,771,054 shares were held short at the 2026-09-30 settlement, 1.4 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is NAUT's daily short volume?
On 2026-10-23, 4,099,094 of the 8,577,239 NAUT shares reported to FINRA were sold short, 47.8% of the day's reported volume. Short volume is a flow for one day, not a position.
Does NAUT have fails to deliver?
The SEC's latest file shows 33,326 NAUT shares failed to deliver at settlement 2026-09-25. Fails are reported per settlement date and published twice a month with a lag.
Are NAUT insiders buying or selling?
No open-market insider trades were reported for NAUT in the last 90 days. The most recent filings are listed below. Latest filing: AH Bio Fund II, L.P. (TenPercentOwner) on 2026-06-02.
Who owns 5% or more of NAUT?
5 holders report 5% or more of NAUT in their latest filing, all on Schedule 13D (active intent). The largest reported stake is Parag Mallick at 17.6% of the class (22,557,411 shares), filed 2026-03-04 for an event on 2026-03-02.
Which tracked 13F managers own NAUT?
4 of the 30 tracked 13F managers held NAUT shares at their latest filing, $5.3M in all. The largest: Ken Griffin's Citadel Advisors (1.9M shares, $3.5M), Renaissance Technologies (691K shares, $1.3M), Izzy Englander's Millennium Management (189K shares, $353K), Steve Cohen's Point72 Asset Management (68K shares, $127K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.